AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Bactiguard Holding

Regulatory Filings Nov 7, 2016

3004_rns_2016-11-07_f45393d1-b137-427f-8cc2-e957abf5b725.pdf

Regulatory Filings

Open in Viewer

Opens in native device viewer

Press release Stockholm, November 7, 2016

New major order from China

Bactiguard has received a new major order from China of 100 000 Bactiguard coated Foley catheters for infection prevention

We have received a new major order from our distributor in China, Jian An Pharmaceuticals. The order is for 100,000 BIP Foley catheters, which is the same quantity as the initial order received in early 2016. The order will be delivered during Q4 2016 and will generate sales revenue of approximately 3 million SEK.

"Sales and marketing activities in China are ongoing with a high level of intensity. Our distributor is well in the process of opening up the first 100 hospital accounts and needs to restock their inventory. We see this repeat order as confirmation that the Chinese market represents a very large potential for Bactiguard." says Cecilia Edström, Vice President Sales & New Business.

This is information that Bactiguard Holding AB (publ) is required to publish in compliance with the Swedish Securities Market Act and/or the Financial Instruments Trading Act. The information was submitted for publication through the agency of the contact person set out below on 7th November 2016, at 08.00.

For further information, please contact:

Johan Rugfelt, COO , mobile: +46 708 724 739

About Bactiguard

Bactiguard is a Swedish medtech company with a mission of preventing healthcare associated infections, reducing the use of antibiotics and saving lives by developing and supplying infection prevention solutions for the healthcare industry. The company's patented coating prevents healthcare associated infections by reducing bacterial adhesion and growth on medical devices. Bactiguardcoated urinary catheters are market leading in the US and Japan, and in recent years the company has developed its own product portfolio of catheters for the urinary and respiratory tract and the blood stream. Bactiguard is currently in a strong expansion phase, focused on new markets in the Europe, Middle East, Asia, South America and Southern Africa. The company has market presence in some 50 countries and has about 60 employees. Its headquarters is located in Stockholm and production facilities in Sweden and Malaysia. Bactiguard is listed on Nasdaq Stockholm. Read more about Bactiguard at www.bactiguard.com.

Talk to a Data Expert

Have a question? We'll get back to you promptly.